| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 117.31B | 117.08B | 113.37B | 115.61B | 111.88B | 101.84B |
| Gross Profit | 15.91B | 15.39B | 14.84B | 14.99B | 14.57B | 12.61B |
| EBITDA | 2.57B | 2.62B | 3.22B | 3.88B | 3.94B | 2.87B |
| Net Income | 971.00M | 1.04B | 2.09B | 2.48B | 3.45B | 1.79B |
Balance Sheet | ||||||
| Total Assets | 69.18B | 70.04B | 66.34B | 64.53B | 62.83B | 56.91B |
| Cash, Cash Equivalents and Short-Term Investments | 16.49B | 15.56B | 14.60B | 14.15B | 12.20B | 10.73B |
| Total Debt | 7.41B | 8.09B | 6.37B | 6.19B | 5.37B | 6.15B |
| Total Liabilities | 45.61B | 46.51B | 42.99B | 42.97B | 43.02B | 39.75B |
| Stockholders Equity | 23.53B | 23.50B | 23.32B | 21.53B | 19.77B | 17.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 996.00M | 1.34B | 1.72B | 3.05B | 2.02B |
| Operating Cash Flow | 0.00 | 1.88B | 3.38B | 1.86B | 3.43B | 2.19B |
| Investing Cash Flow | 0.00 | -1.22B | -1.54B | 364.00M | -532.00M | 877.00M |
| Financing Cash Flow | 0.00 | -278.00M | -1.29B | -376.00M | -1.45B | -541.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥225.30B | 16.88 | ― | 2.83% | 1.49% | -21.76% | |
68 Neutral | ¥19.03B | 11.06 | ― | 3.75% | 4.35% | -34.05% | |
67 Neutral | ¥179.36B | 11.31 | ― | 1.58% | 1.69% | 3.90% | |
67 Neutral | ¥135.43B | 12.62 | ― | 2.85% | 3.83% | 7.24% | |
66 Neutral | ¥128.97B | 8.26 | ― | 3.43% | 0.73% | -9.78% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥61.04B | 19.77 | 0.36% | 2.78% | -6.21% | -29.75% |